Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-04-15Clinical Trial Update: Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients [Phase 2, Phase 3]
Prospective double-blind, placebo-controlled trial of omalizumab (Xolair) in chronic urticaria, spanning Phase 2 and Phase 3 cohorts.
-
FDA approval · 2014-02-24FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) from Kenvue Brands LLC, likely for labeling or indicat…
-
FDA approval · 2014-02-21FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) submitted by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria [Phase 4]
Phase 4 clinical trial evaluating the inhibitory effect of five antihistamines in patients with urticaria has completed.
-
FDA approval · 2014-01-31FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., resulting in labelin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-01-26FDA Approved: ALLERGY RELIEF — Supplemental Application (Ohm Laboratories Inc.)
FDA approved a supplemental application for Allergy Relief containing loratadine from Ohm Laboratories Inc., indicating a regulatory update …
-
FDA label_change · 2013-09-10FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental labeling application for Claritin Chewable Grape and Bubblegum (loratadine) from Bayer HealthCare LLC, updating …
-
FDA approval · 2013-09-09FDA Approved: ALLERGY RELIEF — Supplemental Application (Prodose, Inc)
FDA approved a supplemental application for ALLERGY RELIEF containing cetirizine hydrochloride, submitted by Prodose, Inc.
-
CLINICAL_TRIALS research · 2013-09-09Clinical Trial Update: PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic Diseases
A clinical trial update from the Medical University of Lodz evaluating PF and FeNO and clinical characteristics in children being diagnosed …
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses [Phase 4]
Phase 4 trial comparing adding bedtime hydroxyzine to high-dose levocetirizine versus high-dose levocetirizine alone for corticosteroid-depe…
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mg [Phase 1]
Phase 1 pharmacokinetic comparison of two Bepotastine formulations in allergic rhinitis and urticaria.
-
FDA approval · 2013-06-03FDA Approved: HYDROXYZINE PAMOATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved hydroxyzine pamoate as a generic drug under an Original Application by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuti…
-
FDA approval · 2013-05-28FDA Approved: CHILDRENS CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Children's Cetirizine Hydrochloride from Sun Pharmaceutical Industries, Inc. This action exp…
-
FDA approval · 2013-04-16FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2013-03-26FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer's supplemental application to add a Claritin chewable grape and bubblegum formulation containing loratadine. This exp…
-
FDA approval · 2013-02-28FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer HealthCare LLC's supplemental application for Claritin Allergy (loratadine). This action covers changes related to th…
-
CLINICAL_TRIALS withdrawal · 2013-01-23Clinical Trial Update: Hydroxychloroquine Efficacy in Chronic Urticaria [NA]
A Vanderbilt University-sponsored trial evaluating hydroxychloroquine for chronic urticaria has been withdrawn.
-
FDA approval · 2013-01-04FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a grape and bubblegum flavor for Claritin chewable (loratadine) manufactured by Bayer HealthC…
-
CLINICAL_TRIALS research · 2013-01-03Clinical Trial Update: Platelet Activation in Chronic Inflammatory Skin Diseases
A clinical trial update examines platelet activation in chronic inflammatory skin diseases, including urticaria and atopic dermatitis, with …
-
FDA approval · 2012-12-30FDA Approved: PROMETHEGAN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Cosette Pharmaceuticals' PROMETHEGAN (promethazine hydrochloride), updating its labeling und…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU) [Phase 1, Phase 2]
Pharmacokinetic study of bilastine in children aged 2 to under 12 with allergic rhinoconjunctivitis or chronic urticaria (Phase 1/2). The tr…
-
FDA approval · 2012-09-10FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC HIVES (cetirizine hydrochloride) and finalized its label to cover the treatment of hives …
-
FDA approval · 2012-08-23FDA Approved: ALLEGRA HIVES 24HR — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Allegra Hives 24HR (fexofenadine hydrochloride) by Chattem, Inc., indicating an update to the pr…
-
FDA approval · 2012-08-23FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application to update the labeling for Children's Allegra Allergy (fexofenadine hydrochloride), expanding its pe…
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved Promethazine hydrochloride as an original generic drug application (ANDA) for Cranbury Pharmaceuticals, LLC.